| Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease S Fossati, JR Cejudo, L Debure, E Pirraglia, JY Sone, Y Li, J Chen, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11, 483-492, 2019 | 125 | 2019 |
| Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's … JA Frontera, A Boutajangout, AV Masurkar, RA Betensky, Y Ge, ... Alzheimer's & Dementia 18 (5), 899-910, 2022 | 106 | 2022 |
| Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity ME Solesio, PM Peixoto, L Debure, SM Madamba, MJ De Leon, ... Aging Cell 17 (4), e12787, 2018 | 62 | 2018 |
| Proteomic differences in the hippocampus and cortex of epilepsy brain tissue G Pires, D Leitner, E Drummond, E Kanshin, S Nayak, M Askenazi, ... Brain Communications 3 (2), fcab021, 2021 | 33 | 2021 |
| Type I IFN is siloed in endosomes JB Altman, J Taft, T Wedeking, CN Gruber, M Holtmannspötter, J Piehler, ... Proceedings of the National Academy of Sciences 117 (30), 17510-17512, 2020 | 14 | 2020 |
| P3‐464: Carbonic anhydrase inhibitors ameliorate neurovascular dysfunction IN a mouse model of cerebral amyloid angiopathy F Angiulli, ME Solesio, L Debure, JR Cejudo, T Wisniewski, S Fossati Alzheimer's & Dementia 14 (7S_Part_24), P1296-P1296, 2018 | 14 | 2018 |
| CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans J Ramos‐Cejudo, A Genfi, D Abu‐Amara, L Debure, M Qian, E Laska, ... Psychiatric research and clinical practice 3 (4), 153-162, 2021 | 8 | 2021 |
| FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness E Canepa, R Parodi‐Rullan, R Vazquez‐Torres, B Gamallo‐Lana, ... Alzheimer's & Dementia 19 (11), 5048-5073, 2023 | 7 | 2023 |
| Obstructive sleep apnea and hypertension with longitudinal amyloid-β burden and cognitive changes OM Bubu, SS Kaur, AK Mbah, OQ Umasabor-Bubu, JR Cejudo, L Debure, ... American journal of respiratory and critical care medicine 206 (5), 632-636, 2022 | 7 | 2022 |
| Plasma biomarkers of neurodegeneration and neuroinflammation in hospitalized COVID‐19 patients with and without new neurological symptoms A Boutajangout, J Frontera, L Debure, A Vedvyas, A Faustin, T Wisniewski Alzheimer's & Dementia 17, e057892, 2021 | 7 | 2021 |
| Proteomic differences in the hippocampus and cortex of epilepsy brain tissue. Brain Commun 3: fcab21 G Pires, D Leitner, E Drummond, E Kanshin, S Nayak, M Askenazi, ... | 6 | 2021 |
| Association between lower body temperature and increased tau pathology in cognitively normal older adults EM Blessing, A Parekh, RA Betensky, J Babb, N Saba, L Debure, ... Neurobiology of disease 171, 105748, 2022 | 5 | 2022 |
| Elevation of neurodegenerative serum biomarkers among hospitalized COVID-19 patients JA Frontera, A Boutajangout, AV Masurkar, RA Betensky, Y Ge, ... MedRxiv, 2021.09. 01.21262985, 2021 | 4 | 2021 |
| [P4–133]: DIFFERENTIAL VALUE OF PLASMA TAU AS A BIOMARKER FOR ALZHEIMER'S DISEASE AND CHRONIC TRAUMATIC BRAIN INJURY S Fossati, JR Cejudo, L Debure, E Pirraglia, L Glodzik, RS Osorio, J Chen, ... Alzheimer's & Dementia 13 (7S_Part_27), P1307-P1307, 2017 | 4 | 2017 |
| Carbonic anhydrase inhibition ameliorates Aβ‐induced neurovascular dysfunction in vivo Molecular and cell biology/vascular factors E Canepa, R Vazquez‐Torres, L Debure, S Fossati Alzheimer's & Dementia 16, e044221, 2020 | 1 | 2020 |
| FDA‐approved carbonic anhydrase inhibitors rescue brain Aβ overload, cerebrovascular pathology and gliosis in Alzheimer’s disease model E Canepa, R Vazquez‐Torres, RA Guzman‐Hernandez, L Debure, ... Alzheimer's & Dementia 19, e078985, 2023 | | 2023 |
| Age‐associated biomarker profiles in a non‐human primate model of sporadic CAA S Karimi, AG Patel, BP Nehete, PN Nehete, L Debure, DT Levine, O Cho, ... Alzheimer's & Dementia 19, e080537, 2023 | | 2023 |
| Diagnostic of Novel Plasma Biomarkers in Controls, SCD and MCI Subjects A Boutajangout, AV Masurkar, W Ahmed, L Debure, A Vedvyas, J Links, ... Alzheimer's & Dementia 19, e075989, 2023 | | 2023 |
| The association between anxiety and Alzheimer’s disease plasma biomarkers across stages MA Bernard, A Boutajangout, L Debure, AQ Briggs, A Vedvyas, K Marsh, ... Alzheimer's & Dementia 19, e080554, 2023 | | 2023 |
| Evaluation of biomarker, behavioral, and immunostimulatory profiles following treatment with Class C CpG ODN in a non‐human primate model of sporadic CAA AG Patel, S Karimi, PN Nehete, BP Nehete, S Murray, L Debure, ... Alzheimer's & Dementia 19, e079072, 2023 | | 2023 |
Thomas WisniewskiProfessor of Neurology, Pathology and Psychiatry, New York University School of MedicineVerified email at nyulangone.org
